AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2015
Nov 5, 2015
32566_dirs_2015-11-05_6ce17870-2c13-4bb1-a40d-6acf3bff531d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-11-05
Reporting Person: DREISMANN HEINRICH (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-05 | Common Stock | M | 30000.0 | $25.39 | Acquired | 40000 | Direct |
| 2015-11-05 | Common Stock | S | 30000.0 | $44.4353 | Disposed | 10000 | Direct |
| 2015-11-05 | Common Stock | M | 30000.0 | $27.61 | Acquired | 40000 | Direct |
| 2015-11-05 | Common Stock | S | 30000.0 | $44.4353 | Disposed | 10000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-05 | Non-Qualified Stock Option (right to buy) | $25.39 | M | 30000.0 | Disposed | 2021-12-05 | Common Stock (30000) | Direct |
| 2015-11-05 | Non-Qualified Stock Option (right to buy) | $27.61 | M | 30000.0 | Disposed | 2022-12-05 | Common Stock (30000) | Direct |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2